Short-Term Pharmaceutical Market Forecast Revised Downwards

BMI View: Despite strong underlying fundamentals, Brazil's pharmaceutical market growth rate is expected to slow due to concerns over the country's long-term fiscal policy and, to a lesser extent, deteriorating investor attitudes towards the financing of local construction projects. Nevertheless, Brazil remains a very attractive emerging market for pharmaceutical

To read the full article, please choose one of the following options: